Announcements Trials

Browse Landscape Eligibility

Clinical Trials

4 trials

Recent Start date Enrollment

Phase 3 × Colitis, Ulcerative × etrolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 4

Sponsor

Conditions

Colitis, Ulcerative 4

Interventions

etrolizumab 4 Ringer's Lactate 1 Mesalamine 1 Loperamide 1 Injections 1 Infliximab 1 Hydroxyethyl Starch Derivatives 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed

397 enrolled 32 charts

Colitis, Ulcerative

NCT02165215 2021-08-19

LAUREL

Hoffmann-La Roche

Phase 3 Completed

359 enrolled 34 charts

Colitis, Ulcerative

NCT02100696 2021-08-13

HICKORY

Hoffmann-La Roche

Phase 3 Completed

609 enrolled 52 charts

Colitis, Ulcerative

NCT02163759 2021-07-23

HIBISCUS I

Hoffmann-La Roche

Phase 3 Completed

358 enrolled 42 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡